Advertisement

European Journal of Pediatrics

, Volume 152, Issue 7, pp 615–618 | Cite as

The effect of sodium cromoglycate on upper and lower respiratory symptoms in children born prematurely

  • B. Yuksel
  • A. Greenough
Pneumology

Abstract

The aims of this study were to assess whether sodium cromoglycat (SCG) was an effective prophylaxis against both upper and lowr respiratory tract signs and to determine factors which affected the site and magnitude of the response to SCG. Sixteen children born prematurely were entered into a randomised placebocontrolled trial at 15 months of age (range 4–31 months). The patients received, in random order, either 3 weeks' treatment with SCG (5 mg) or placebo, both given four times a day by inhalation via a spacer device. Parents were asked to record the occurrence and severity of their child's upper respiratory tract signs; sneezing and runny nose and lower respiratory tract signs; day and night time cough and wheeze. During the active compared to the placebo period there was an overall reduction of 47% and 53% in upper and lower respiratory tract signs, respectively. The magnitude of response to SCG as assessed by either the change in upper or lower respiratory tract signs was not significantly related to the patient's gestational or postnatal age, the occurrence of neonatal chronic lung disease, family history of atopy or the order in which the therapy was administered. We conclude that inhaled SCG may be a useful prophylaxis for both upper and lower respiratory tract signs for children born prematurely and less than 3 years of age.

Key words

Allergy Chronic lung disease Prematurity Sodium cromoglycate 

Abbreviation

SCG

sodium cromoglycate

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Geller-Bernstein C, Levin S (1982) Nebulised sodium cromoglycate in the treatment of wheezy bronchitis in infants and young children. Respiration 43:294–298PubMedGoogle Scholar
  2. 2.
    Greenough A, Yuksel B, Maconochie I (1990) Recurrent respiratory symptoms in the first year of life following preterm delivery. J Perinat Med 18:489–494PubMedGoogle Scholar
  3. 3.
    Handelman NI, Friday GA, Schwartz HJ (1977) Cromolyn sodium nasal solution in the prophylactic treatment of polleninduced seasonal allergic rhinitis. A tri-city study of efficacy and safety. J Allergy Clin Immunol 59:237–242CrossRefPubMedGoogle Scholar
  4. 4.
    Henry RL, Hiller EJ, Milner AD, Hodges IGS, Stokes GM (1984) Nebulised ipratropium bromide and sodium cromoglycate in the first two years of life. Arch Dis Child 59:54–57PubMedGoogle Scholar
  5. 5.
    Holgate ST (1989) Reflections on the mechanism(s) of action of sodium cromoglycate (Intal) and the role of mast cells in asthma. Respir Med 83 [Suppl]:25S-31SGoogle Scholar
  6. 6.
    Miraglia del Giudice M, Capristo A, Maiello N, Apuzzo G (1982) Nebulised sodium cromoglycate for the treatment of asthma in children under 5 years of age. Mod Probl Pediatr 21:122–127Google Scholar
  7. 7.
    O'Callaghan C, Milner AD, Swarbrick A (1990) Nebulised sodium cromoglycate in infancy: airway protection after deterioration. Arch Dis Child 65:404–406PubMedGoogle Scholar
  8. 8.
    Patalano F, Ruggieri F (1989) Sodium cromoglycate: a review. Eur Respir J 2 [Suppl 6]:556S-560SGoogle Scholar
  9. 9.
    Sibbard B (1980) Extrinsic and intrinsic asthma: influence of classification on family history of asthma and allergic disease. Clin Allergy 10:313–318PubMedGoogle Scholar
  10. 10.
    Stenmark KR, Eyzaguirre M, Remigio L, Seccombe J, Hensen PM (1985) Recovery of platelet activating factor and leukotrienes from infants with severe bronchopulmonary dysplasia: clinical improvement with cromolyn treatment. Am Rev Respir Dis 131:236AGoogle Scholar
  11. 11.
    Yuksel B, Greenough A (1991) Ipratropium bromide in symptomatic preterm infants. Eur J Pediatr 150:854–857PubMedGoogle Scholar
  12. 12.
    Yuksel B, Greenough A (1991) Effect of nebulised salbutamol in preterm infants during the first year of life. Eur Respir J 4:1088–1092PubMedGoogle Scholar
  13. 13.
    Yuksel B, Greenough A (1992) Inhaled sodium cromoglycate for preterm children with respiratory symptoms at follow up. Respir Med 86:131–134PubMedGoogle Scholar
  14. 14.
    Yuksel B, Greenough A, Maconochie I (1990) Effective bronchodilator therapy by a simple spacer device for wheezy premature infants in the first two years of life. Arch Dis Child 65:782–785PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • B. Yuksel
    • 1
  • A. Greenough
    • 1
  1. 1.Department of Child HealthKing's College HospitalLondonUK

Personalised recommendations